Galectin Therapeutics (GALT) EBITDA (2010 - 2017)
Galectin Therapeutics (GALT) posted EBITDA of -$8.18 million for Q2 2021, compared with -$6.09 million a year earlier.
Powered by 
Analysis
Galectin Therapeutics (GALT) EBITDA (2010 - 2017) Analysis & Trends
For the trailing twelve months through Jun 30, 2021, EBITDA at Galectin Therapeutics was -$28.23 million; for FY2020, it was -$23.41 million.
- In prior years, Galectin Therapeutics' EBITDA was -$13.4 million in FY2019, -$13.6 million in FY2018, -$16.25 million in FY2017 and -$21.47 million in FY2016.
- The Q2 2021 figure stands as the lowest quarterly EBITDA in data going back to Q3 2010.
- According to Business Quant data, EBITDA for the three prior quarters was -$6.31 million (Q1 2021), -$7.82 million (Q4 2020) and -$5.92 million (Q3 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Galectin Therapeutics | 222.99 Mn | 166.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | -2.37 Mn |
| Sep 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.51 Mn |
| Mar 31, 2017 | -4.95 Mn |
| Dec 31, 2016 | -4.60 Mn |
| Sep 30, 2016 | -4.54 Mn |
| Jun 30, 2016 | -5.53 Mn |
| Mar 31, 2016 | -6.81 Mn |
| Dec 31, 2015 | -4.68 Mn |
| Sep 30, 2015 | -5.90 Mn |
| Jun 30, 2015 | -4.66 Mn |
| Mar 31, 2015 | -4.84 Mn |
| Dec 31, 2014 | -3.73 Mn |
| Sep 30, 2014 | -3.47 Mn |
| Jun 30, 2014 | -3.37 Mn |
| Mar 31, 2014 | -4.84 Mn |
| Dec 31, 2013 | -2.80 Mn |
| Sep 30, 2013 | -3.54 Mn |
| Jun 30, 2013 | -2.54 Mn |
| Mar 31, 2013 | -3.21 Mn |
API Access
Galectin Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();